Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Sangamo Therapeutics, Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- −24 vs. Q2 2024
- Shares held
- 56.2M
- −26.0M (−31.6%) vs. Q2 2024
- Total value
- $48.6M
- +$19.2M (+65.2%) vs. Q2 2024
- New holders
- 16
- 24 more added
- Sold out
- 40
- 34 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $29.0K |
| Q1 2026 | 112 | $26.0M |
| Q4 2025 | 105 | $26.2M |
| Q3 2025 | 112 | $42.1M |
| Q2 2025 | 114 | $39.6M |
| Q1 2025 | 122 | $34.5M |
| Q4 2024 | 128 | $62.9M |
| Q3 2024 | 103 | $48.6M |
| Q2 2024 | 129 | $31.1M |
| Q1 2024 | 131 | $68.2M |
| Q4 2023 | 130 | $47.2M |
| Q3 2023 | 135 | $61.3M |
| Q2 2023 | 152 | $137.4M |
| Q1 2023 | 180 | $197.6M |
| Q4 2022 | 182 | $326.0M |
| Q3 2022 | 197 | $477.2M |
| Q2 2022 | 188 | $371.1M |
| Q1 2022 | 195 | $459.6M |
| Q4 2021 | 193 | $577.0M |
| Q3 2021 | 193 | $679.3M |
| Q2 2021 | 197 | $912.0M |
| Q1 2021 | 203 | $994.7M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 9,597,777 | $8.31M | 0.00% | −2,300,640−19.3% | Reduced |
| Wasatch Advisors Inc | 19,442,368 | $16.8M | 0.08% | −648,202−3.2% | Reduced |
| International Assets Investment Management, LLC | 34,731 | – | – | −6,404−15.6% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −14,060,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,560,770−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −1,165,993−100.0% | Sold out |
| Long Focus Capital Management, LLC | 0 | $0 | 0.00% | −1,098,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −820,355−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −744,102−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −335,119−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −308,500−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −264,441−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −199,788−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −185,813−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −128,230−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −94,700−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −75,274−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −74,842−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −63,840−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −59,653−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −57,721−100.0% | Sold out |
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −38,000−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −38,200−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −36,548−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −36,500−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −31,773−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −29,625−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −29,535−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,383−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −21,047−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −19,559−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −19,955−100.0% | Sold out |
| McGlone Suttner Wealth Management, Inc. | 0 | $0 | 0.00% | −11,083−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −13,250−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −13,083−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Avantax Advisory Services, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −1,337−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −1,038−100.0% | Sold out |
| Abich Financial Wealth Management LLC | 0 | $0 | 0.00% | −418−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −865−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |